PRUCCOLI, LETIZIA
 Distribuzione geografica
Continente #
AS - Asia 2.477
NA - Nord America 2.222
EU - Europa 1.929
SA - Sud America 170
AF - Africa 155
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 2
Totale 6.966
Nazione #
US - Stati Uniti d'America 2.167
IT - Italia 811
CN - Cina 671
VN - Vietnam 623
SG - Singapore 615
DE - Germania 202
GB - Regno Unito 193
SE - Svezia 159
HK - Hong Kong 148
BR - Brasile 122
IN - India 108
KR - Corea 93
FR - Francia 92
NL - Olanda 92
RU - Federazione Russa 66
FI - Finlandia 60
IE - Irlanda 59
JP - Giappone 35
TG - Togo 35
CI - Costa d'Avorio 34
BG - Bulgaria 33
ZA - Sudafrica 33
CA - Canada 31
ID - Indonesia 28
SC - Seychelles 28
TW - Taiwan 26
AR - Argentina 21
ES - Italia 21
BD - Bangladesh 20
PH - Filippine 20
AT - Austria 17
BE - Belgio 16
IQ - Iraq 15
MX - Messico 13
UA - Ucraina 13
EE - Estonia 12
JO - Giordania 12
PL - Polonia 12
HR - Croazia 11
TR - Turchia 11
CH - Svizzera 10
PT - Portogallo 10
AU - Australia 9
CZ - Repubblica Ceca 9
TH - Thailandia 9
EC - Ecuador 8
EG - Egitto 8
GR - Grecia 8
CL - Cile 7
PK - Pakistan 7
MY - Malesia 6
IR - Iran 5
LT - Lituania 5
NG - Nigeria 5
DK - Danimarca 4
MA - Marocco 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
BO - Bolivia 3
CO - Colombia 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
KZ - Kazakistan 3
RO - Romania 3
SA - Arabia Saudita 3
VE - Venezuela 3
AZ - Azerbaigian 2
DZ - Algeria 2
HU - Ungheria 2
LB - Libano 2
LK - Sri Lanka 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
PY - Paraguay 2
TN - Tunisia 2
A1 - Anonimo 1
AM - Armenia 1
BY - Bielorussia 1
DM - Dominica 1
ET - Etiopia 1
GH - Ghana 1
GT - Guatemala 1
HN - Honduras 1
JM - Giamaica 1
KE - Kenya 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
LU - Lussemburgo 1
LV - Lettonia 1
MT - Malta 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
YE - Yemen 1
Totale 6.966
Città #
Singapore 421
Bologna 279
Ashburn 269
Hefei 204
Southend 154
Chandler 143
San Jose 136
Fairfield 135
Hong Kong 134
Ho Chi Minh City 133
Hanoi 126
Santa Clara 112
Dong Ket 99
Council Bluffs 82
Seoul 77
Woodbridge 73
Beijing 71
Houston 70
Ann Arbor 63
Seattle 62
New York 60
Cambridge 56
Wilmington 56
Redmond 54
Dublin 53
Los Angeles 53
Princeton 50
Boardman 47
Helsinki 47
Milan 42
Lauterbourg 38
Lomé 35
Abidjan 34
Sofia 33
Dallas 31
San Giorgio di Piano 30
Tokyo 29
Da Nang 26
Berlin 21
Buffalo 21
Jakarta 21
Johannesburg 20
Rimini 20
San Diego 20
Cesena 19
Nanjing 19
Frankfurt am Main 18
Portogruaro 18
Bremen 17
Bengaluru 16
Brussels 16
Hyderabad 16
Forlì 14
Haiphong 14
Rome 14
São Paulo 14
Amsterdam 13
Nuremberg 13
Redondo Beach 13
Westminster 13
Amman 12
Cervia 12
Guangzhou 12
Munich 12
Phoenix 12
Biên Hòa 11
Boydton 11
Florence 11
Redwood City 11
Bari 10
Chicago 10
Des Moines 10
Falkenstein 10
Hải Dương 10
Lappeenranta 10
Modena 9
Salt Lake City 9
Shenyang 9
Stockholm 9
Turin 9
Jinan 8
Kaohsiung 8
Montreal 8
Orem 8
Padova 8
Saint Petersburg 8
Thái Nguyên 8
Toronto 8
Venezia 8
Hangzhou 7
London 7
Shanghai 7
Vienna 7
Baghdad 6
Changsha 6
Delhi 6
Faenza 6
Forlimpopoli 6
Madrid 6
Nha Trang 6
Totale 4.338
Nome #
Comparison of Adaptive Neuroprotective Mechanisms of Sulforaphane and its Interconversion Product Erucin in in Vitro and in Vivo Models of Parkinson's Disease 367
PROTAC-Induced Glycogen Synthase Kinase 3β Degradation as a Potential Therapeutic Strategy for Alzheimer’s Disease 335
Discovery of novel benzofuran-based compounds with neuroprotective and immunomodulatory properties for Alzheimer's disease treatment 330
Multitarget Strategy to Address Alzheimer's Disease: Design, Synthesis, Biological Evaluation, and Computational Studies of Coumarin-Based Derivatives 288
Dysregulation of long non-coding RNAs in neuroinflammation: characterization of LINC00520 and its possible role in Parkinson's disease 280
PROTAC-INDUCED GLYCOGEN SYNTHASE KINASE 3B DEGRADATION 237
Exploiting the chalcone scaffold to develop multifunctional agents for Alzheimer’s disease 212
Targeting the multifaceted neurotoxicity of Alzheimer's disease by tailored functionalisation of the curcumin scaffold 203
PQM130, a novel feruloyl-donepezil hybrid compound, effectively ameliorates the cognitive impairments and pathology in a mouse model of Alzheimer's disease 203
The Keap1/Nrf2-ARE pathway as a pharmacological target for chalcones 201
Naturally inspired molecules as multifunctional agents for Alzheimer's disease treatment 196
Heat stress as a potential risk factor for vitamin D deficiency 192
Antioxidant and Neuroprotective Effects of Fucoxanthin and Its Metabolite Fucoxanthinol: A Comparative In Vitro Study 191
Design, synthesis and evaluation of novel feruloyl-donepezil hybrids as potential multitarget drugs for the treatment of Alzheimer's disease 190
Novel Curcumin-Diethyl Fumarate Hybrid as a Dualistic GSK-3β Inhibitor/Nrf2 Inducer for the Treatment of Parkinson's Disease 190
Esculetin as a Bifunctional Antioxidant Prevents and Counteracts the Oxidative Stress and Neuronal Death Induced by Amyloid Protein in SH-SY5Y Cells 188
Design, synthesis and pharmacological evaluation of N-benzyl-piperidinyl-aryl-acylhydrazone derivatives as donepezil hybrids: Discovery of novel multi-target anti-alzheimer prototype drug candidates 172
Antioxidant and Anti-Melanogenesis Effects of Teucrium chamaedrys L. Cell Suspension Extract and Its Main Phenylethanoid Glycoside in B16-F10 Cells 171
Cinnamoyl-N-Acylhydrazone-Donepezil Hybrids: Synthesis and Evaluation of Novel Multifunctional Ligands Against Neurodegenerative Diseases 171
Synthesis and pharmacological evaluation of novel N-aryl-cinnamoyl-hydrazone hybrids designed as neuroprotective agents for the treatment of Parkinson’s disease 168
Synthesis and biological evaluation of 4-hydroxy-methylpiperidinyl-N-benzyl-acylarylhydrazone hybrids designed as novel multifunctional drug candidates for Alzheimer’s disease 167
Design, synthesis, and biological evaluation of new thalidomide–donepezil hybrids as neuroprotective agents targeting cholinesterases and neuroinflammation 160
Combined inhibition of the EGFR/AKT pathways by a novel conjugate of quinazoline with isothiocyanate. 151
Protective effects of chrysin against the neurotoxicity induced by aluminium: In vitro and in vivo studies 148
Design, Synthesis and Biological Evaluation of Novel Triazole N-acylhydrazone Hybrids for Alzheimer's Disease 145
null 141
Pyridinylimidazoles as GSK3β Inhibitors: The Impact of Tautomerism on Compound Activity via Water Networks 129
A novel arylpiperazine derivative (LQFM181) protects against neurotoxicity induced by 3- nitropropionic acid in in vitro and in vivo models 128
Chalcone-based carbamates for Alzheimer's disease treatment 128
Optimization of the Extraction from Spent Coffee Grounds Using the Desirability Approach 126
Esculetin provides neuroprotection against mutant huntingtin-induced toxicity in huntington’s disease models 126
Curcumin and Heme Oxygenase: Neuroprotection and Beyond 123
null 118
Development of new extracts of crocus sativus l. By-product from two different italian regions as new potential active ingredient in cosmetic formulations 117
Glycosylation of chrysin with β-d-glucose tetraacetate (LQFM280) enhances its in vitro and in vivo neuroprotective effects against the toxicity induced by 3-nitropropionic acid 110
New antioxidant ingredients from brewery by-products for cosmetic formulations 109
Quinazoline based α1-adrenoreceptor antagonists with potent antiproliferative activity in human prostate cancer cell lines 105
Influence of Guanine-Based Purines on the Oxidoreductive Reactions Involved in Normal or Altered Brain Functions 99
null 79
Exploring the anti-inflammatory activity of sulforaphane metabolites 66
Antioxidant and neuroprotective effects of ubiquinol diacetate: Insights from SH-SY5Y cell line and Caenorhabditis elegans models of Parkinson's disease 59
Rational optimization of D3R/GSK-3β dual target-directed ligands as potential treatment for bipolar disorder: Design, synthesis, X-ray crystallography, molecular dynamics simulations, in vitro ADME, and in vivo pharmacokinetic studies 59
Targeting Alzheimer’s disease neurotoxicity by functionalization of the chalcone scaffold 56
null 52
Effetti Antiossidanti e Antinfiammatori del Nutraceutico Sulforafano e dei suoi Metaboliti: uno Studio Comparativo in Modelli in vitro 48
Design and synthesis of H 2 S-donor hybrids: A new treatment for Alzheimer's disease? 27
Totale 7.261
Categoria #
all - tutte 20.279
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.279


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021185 0 0 0 0 0 0 0 0 0 0 40 145
2021/2022691 34 8 32 45 52 45 23 83 69 95 119 86
2022/2023645 64 76 27 75 68 51 41 51 104 12 51 25
2023/2024559 25 54 54 70 31 95 38 70 15 32 35 40
2024/20251.264 76 120 99 75 194 65 112 71 37 102 113 200
2025/20262.937 225 323 258 216 262 150 341 177 607 293 85 0
Totale 7.261